loader image

- Advertisement -
Your text

Friday, December 19, 2025
62.3 F
McAllen
- Advertisement -
Home Blog Page 1916
Image for illustration only

Cornyn Releases Letter to Texans on National Purple Heart Day

TBB Staff -
Texas Border Business AUSTIN — U.S. Senator John Cornyn (R-TX) released the following open letter to Texans on National Purple Heart Day: August 7, 2018 Dear Fellow...

McAllen Public Library Launches Local Author Collection

TBB Staff -
Texas Border Business McAllen - McAllen Public Library invites local authors to donate one copy of each of their published books to the library for inclusion...
The Weslaco Chamber of Commerce will host its next Morning Meet Up on Tuesday, Aug. 14 at Weslaco’s Daily Grind. Pictured: Elizabeth Vargas, U.S. SBA Office of Disaster Assistance (left) and Laura Espinoza, Weslaco Chamber of Commerce (right).

Weslaco Chamber of Commerce to host Morning Meet Up Aug. 14

TBB Staff -
Texas Border Business The Weslaco Chamber of Commerce will host its next Morning Meet Up on Tuesday, August 14 at 7:30 am at Weslaco's Daily...
Leadership Mid Valley applications are now available online. Class XIV begins this September, and will end in May of 2019. Pictured: Leadership Mid Valley Class XIII.

Weslaco Chamber Accepting Applications for Leadership Mid Valley

TBB Staff -
Texas Border Business The Weslaco Chamber of Commerce is now accepting applications for Leadership Mid Valley Class XIV to begin in late September 2018.  Sponsored...

Night Work Scheduled on FM 802 in BROWNSVILLE

TBB Staff -
Texas Border Business PHARR – The Texas Department of Transportation announces that Foremost Paving, Inc., a TxDOT contractor will be performing repair to controlled and...

Cornyn: Accomplishments Grow Under GOP Senate

TBB Staff -
Texas Border Business U.S. Senator John Cornyn (R-TX) and Senate Republicans continue to build on their record of accomplishment in the 115th Congress by passing...
Edinburg CISD Superintendent Dr. René Gutiérrez speaks to administrators, directors and principals during the district’s annual Leadership Academy at the Edinburg Conference Center at Renaissance.

Edinburg CISD leaders learn about ‘Building and Transforming Our Community’

TBB Staff -
Texas Border Business EDINBURG – Edinburg Consolidated Independent School District Superintendent Dr. René Gutiérrez recently announced that the theme for this school year will be...
By Amanda L. Alaniz Rio Grande Valley, Texas – Researchers at The University of Texas Rio Grande Valley’s Department of Health and Biomedical Sciences are working to develop a next generation of anti-HIV drugs that are more effective and have fewer side effects To further support the study of human immunodeficiency virus 1 (HIV-1) – still one of the leading causes of death worldwide, predominantly in developing countries – the National Institutes of Health (NIH) recently awarded a grant to the UTRGV researchers for their project, called “Nanodiamond Based Anti-HIV Drug Delivery Targeted Towards the Brain.” The grant is for $432,729, starting July 1, 2018 and ending June 30, 2021. The principal investigator is Dr. Upal Roy, assistant professor at the UTRGV Department of Health and Biomedical Science. Collaborators are Dr. Shizue Mito, assistant professor in the UTRGV Department Chemistry, and Dr. Vadym Drozd, assistant professor in the Department of Mechanical and Materials Engineering at Florida International University. The proposed research develops a molecule that will be conjugated with the microglia-specific antibody for targeted drug delivery to the brain. Microglia is a type of cell that is majorly found throughout the brain. The proposed nanodrug can be used to directly deliver an anti-HIV drug specifically to the inflammatory areas of the brain where most of the infected microglia and the virus are present. Roy and his colleagues hypothesize that the nanodiamond-mediated drug delivery will be more efficient, safe and effective than conventional drugs. “The patients will find these next-generation drugs less expensive, and with the simplified dosing schedule, they will stay in the treatment for a much longer period of time – which eventually will improve the quality of their lives,” he said. The proposed research will help to stimulate the research environment at UTRGV, Roy said, and will expose current undergraduate and graduate students to the biomedical research environment. “This research work is very translational, which will eventually reach the patients in need in the Rio Grande Valley who are affected by this disease. It will put UTRGV on the national map for HIV research, which can also help us bring more research funding to this region,” he said. Roy extends credit to the UTRGV Health and Biomedical Science Department for supporting the project, and Dr. Saraswathy Nair, the department chair and associate professor; Dr. Michael Lehker, dean of College of Health Affairs; Dr. Shawn Saladin, associate professor and associate dean for the School of Rehabilitation Services and Counseling; and Dr. John Krouse, dean of the UTRGV School of Medicine. ABOUT UTRGV The University of Texas Rio Grande Valley (UTRGV) was created by the Texas Legislature in 2013 as the first major public university of the 21st century in Texas. This transformative initiative provided the opportunity to expand educational opportunities in the Rio Grande Valley, including a new School of Medicine, and made it possible for residents of the region to benefit from the Permanent University Fund – a public endowment contributing support to the University of Texas System and other institutions. UTRGV has campuses and off-campus research and teaching sites throughout the Rio Grande Valley including in Boca Chica Beach, Brownsville (formerly The University of Texas at Brownsville campus), Edinburg (formerly The University of Texas-Pan American campus), Harlingen, McAllen, Port Isabel, Rio Grande City, and South Padre Island. UTRGV, a comprehensive academic institution, enrolled its first class in the fall of 2015, and the School of Medicine welcomed its first class in the summer of 2016. CUTLINE Researchers in the UTRGV Department of Health and Biomedical Sciences are working to develop a next generation of anti-HIV drugs that are more effective and have fewer side effects. Human immunodeficiency virus 1 (HIV-1) remains one of the leading causes of death globally. To further support studies into HIV-1, the National Institutes of Health awarded UTRGV a grant for the project, called “Nanodiamond Based Anti-HIV Drug Delivery Targeted Towards the Brain,” The grant is for $432,729 starting July 1, 2018 and ending June 30, 2021. The principal investigator is Dr. Upal Roy, assistant professor at the UTRGV Department of Health and Biomedical Science. Pictured here are Roy and some of the students majoring in Biomedical Science who will be working on the research: from left, Jonathan Abshier, Roberto DeLa Garza, Roy, Jesus Hernandez and Hari Das. (Courtesy Photo)

UTRGV Awarded Grant for Anti-HIV Drug Research

TBB Staff -
Texas Border Business By Amanda L. Alaniz Rio Grande Valley, Texas – Researchers at The University of Texas Rio Grande Valley’s Department of Health and Biomedical...

ParkMobile to Partner with Metro McAllen

TBB Staff -
Park Mobile will provide smart parking app to City of McAllen Texas Border Business ParkMobile, the leading provider of smart parking and mobility solutions in the...

Tigres UANL to Face Off Against Atlas de Guadalajara at H-E-B Park in a...

TBB Staff -
Texas Border Business Edinburg, Texas - Two Liga MX teams will face off at the H-E-B Park on Saturday, Sept 8, 2018. The six (6)...
1...1,9151,9161,917...2,227Page 1,916 of 2,227

TOP STORIES

About Us

We are regarded by the business community as one of the most valuable credible sources of commerce news in the Rio Grande Valley. We are your connection to the business community!

Pick up a copy of our publication on more than 800 locations Valley-wide.

Contact Us

General Box (956) 928-1255

Sales Info (956) 451-4585

info@tbbmega.com

sales@tbbmega.com

Subscribe

© 2025 Texas Border Business